Control of viral infections by epigenetic-targeted therapy

作者: Zeina Nehme , Sébastien Pasquereau , Georges Herbein

DOI: 10.1186/S13148-019-0654-9

关键词:

摘要: Epigenetics is defined as the science that studies modifications of gene expression are not owed to mutations or changes in genetic sequence. Recently, strong evidences pinpointing toward a solid interplay between such epigenetic alterations and outcome human cytomegalovirus (HCMV) infection. Guided by previous possibly promising experimental trials immunodeficiency virus (HIV) reprogramming, latter paving road two major approaches control viral latency. Reactivating HCMV from latent phase (“shock kill” paradigm) alternatively repressing lytic reactivation phases (“block lock” epigenetic-targeted therapy represent encouraging options overcome latency shedding otherwise replication infectivity, which could lead eventually infection its complications. Not limited HIV HCMV, this concept similarly studied context hepatitis B C virus, herpes simplex Epstein-Barr virus. Therefore, manipulations stand pioneering research area modern biology constitute curative methodology potentially consenting development broad-spectrum antivirals infections vivo.

参考文章(207)
David G. Anders, Julie A. Kerry, Gregory S. Pari, DNA synthesis and late viral gene expression Cambridge University Press. ,(2007) , 10.1017/CBO9780511545313.020
Human Cytomegalovirus (HCMV) – Revised Transfusion Medicine and Hemotherapy. ,vol. 37, pp. 365- 375 ,(2010) , 10.1159/000322141
David E. Tunkel, Stacey L. Ishman, Eugene A. Chu, Julie M. Wu, Nasopharyngeal carcinoma: the role of the Epstein-Barr virus. The Medscape Journal of Medicine. ,vol. 10, pp. 165- 165 ,(2008)
Sophie Bouchat, Nadège Delacourt, Anna Kula, Gilles Darcis, Benoit Van Driessche, Francis Corazza, Jean‐Stéphane Gatot, Adeline Melard, Caroline Vanhulle, Kabamba Kabeya, Marion Pardons, Véronique Avettand‐Fenoel, Nathan Clumeck, Stéphane De Wit, Olivier Rohr, Christine Rouzioux, Carine Van Lint, Sequential treatment with 5‐aza‐2′‐deoxycytidine and deacetylase inhibitors reactivates HIV‐1 Embo Molecular Medicine. ,vol. 8, pp. 117- 138 ,(2016) , 10.15252/EMMM.201505557
Michael J. Cannon, Terri B. Hyde, D. Scott Schmid, Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection. Reviews in Medical Virology. ,vol. 21, pp. 240- 255 ,(2011) , 10.1002/RMV.695
Anna Wald, Lawrence Corey, Persistence in the population: epidemiology, transmission Human herpesviruses: biology, therapy, and immunoprophylaxis.. pp. 795- 813 ,(2007) , 10.1017/CBO9780511545313.037
George Miller, Ayman El‐Guindy, Jill Countryman, Jianjiang Ye, Lyn Gradoville, Lytic cycle switches of oncogenic human gammaherpesviruses. Advances in Cancer Research. ,vol. 97, pp. 81- 109 ,(2007) , 10.1016/S0065-230X(06)97004-3
Qing Xie, Linlin Chen, Xuefeng Shan, Xiaoliang Shan, Jia Tang, Fan Zhou, Qingmei Chen, Huiqin Quan, Dan Nie, Wenlu Zhang, Ai-Long Huang, Ni Tang, Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway. International Journal of Cancer. ,vol. 135, pp. 635- 646 ,(2014) , 10.1002/IJC.28697
AdityaKumar Bubna, Vorinostat-An overview Indian Journal of Dermatology. ,vol. 60, pp. 419- 419 ,(2015) , 10.4103/0019-5154.160511
Valentina Montessori, Julio S.G. Montaner, Linda Akagi, Marianne Harris, Natasha Press, Adverse effects of antiretroviral therapy for HIV infection Canadian Medical Association Journal. ,vol. 170, pp. 229- 238 ,(2004)